Cite
APA Citation
De Vita, S., Quartuccio, L., Seror, R., Salvin, S., Ravaud, P., Fabris, M., Nocturne, G., Gandolfo, S., Isola, M., & Mariette, X. (n.d.). tHU0392 Efficacy and Safety of Belimumab Given for 12 Months in Primary sjögren's Syndrome: The Beliss Open-Label Phase II Study. Annals of the rheumatic diseases, 74, 338–339. http://access.bl.uk/ark:/81055/vdc_100135159998.0x000051